Skip to main content

Phytochemical profiling and bioactivity analysis of Citrus japonica leaves volatile oil from Palestine

Abstract

Background

Exploring the therapeutic potential of unutilized plant parts from agricultural crops represents a promising strategy for discovering novel medications with high positive economic value. This study aimed to characterize the composition, antidiabetic, anti-obesity, antioxidant, and cytotoxic effects of volatile oil (VO) extracted from the leaves of Citrus japonica trees. This is the first research to assess the C. japonica VO’s anti-obesity, anti-lipase, and cytotoxic properties. Using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assays and gas chromatography–mass spectrometry (GC–MS) analysis, the components of VO and its capacity to suppress the growth of cancer and other abnormal cells were ascertained, respectively. Stable 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radicals, p-nitrophenyl butyrate (PNPB), and dinitrosalicylic acid (DNSA) assays were employed to determine antioxidant, anti-obesity, and antidiabetic activities, respectively.

Results

The C. japonica leaf showed significant diversity in type and percentage of VO molecules. Overall, 45 compounds were identified in the VO, constituting 99.69% of the total oil composition. γ-Muurolene (28.12%), β-eudesmol (10.93%), γ-eudesmol (8.44%), germacrene B (7.39%), and elemol (7.27%) are the major characterized molecules. According to the inhibition percentage results of DPPH free radicals, porcine pancreatic lipase, and α-amylase, the VO exhibits strong antioxidant properties and weak inhibitory effects on lipase and α-amylase enzymes. The C. japonica VO showed a moderate cytotoxic effect against Hep3B and considerable activity on B16F1, CaCo-2, HeLa, MCF-7, and HepG2, with IC50 doses in the range of 69.7–171.96 µg/mL. The VO cytotoxic effect IC50 against the normal cell line LX-2 was 224.95 µg/mL.

Conclusion

The current study collectively presented the chemical constituents of C. japonica leaf VO from Palestine for the first time and demonstrated its inhibitory effects against DPPH free radicals, porcine pancreatic lipase, and α-amylase. The results suggest that C. japonica leaf VO has the potential to be used as a natural supplement to prevent or treat cancer, as well as in the food industry as a natural antioxidant.

Graphical Abstract

Introduction

Volatile oils (VOs) have been an important part of medicine for generations, offering a natural and integrative approach to wellness and healing. The medicinal qualities of these purified plant oils range from stress reduction and pain treatment to anti-inflammatory and antimicrobial actions. The versatility of VOs in supplementing traditional treatment and their ability to improve persons' general health and vigor make them a valuable tool in modern healthcare [1,2,3]. VOs have made their way into mainstream medicine in addition to their usage in aromatherapy. They are becoming more well-known for their antibacterial, antifungal, and antiviral characteristics, which have led to their inclusion in therapies for various ailments. Furthermore, studies have revealed that several VOs have analgesic effects, offering them a natural alternative for pain relief. The use of VOs in modern medical practices indicates rising respect for the potential advantages of natural remedies, providing patients with various options that correspond with an integrated healthcare strategy while also helping develop novel medicines [4,5,6].

Citrus japonica Thunb. is also referred to synonymously as Fortunella japonica (Thunb.) Swingle belongs to the Rutaceae family and is native to the Asia–Pacific and South Asia. It has many traditional therapeutic benefits: expectorant, carminative, antivirus, and inflammatory [7].

Cancer is a serious global medical issue that impacts individuals and communities on a personal and emotional level, as well as affecting societal, economic, and psychological aspects of life. It transcends borders, cultures, and demographics, highlighting the need for collaborative efforts in research, prevention, and access to quality healthcare. Addressing both the quantitative aspects of cancer, such as incidence and mortality rates, and the qualitative aspects is essential, as the effects of cancer extend far beyond a medical diagnosis [8, 9]. Diabetes mellitus, a chronic condition characterized by high blood glucose levels, is a serious global health issue [10]. It poses significant challenges for healthcare systems, requiring extensive research and effective mitigation strategies [11]. The number of people with diabetes has surged from 108 million in 1980 to 422 million in 2014, driven by sedentary lifestyles, poor nutrition, and an aging population [12]. This condition imposes a substantial financial burden on healthcare systems and individuals due to the costs of prescriptions, hospitalizations, and treatments for complications [13].

Obesity has emerged as a crucial global healthcare problem, posing significant health hazards and putting pressure on healthcare systems across the world [14, 15]. According to the World Health Organization (WHO), approximately 650 million adults and 340 million children were obese in 2016 [16]. Oxidative stress, caused by an imbalance in the body's free radicals and antioxidants, has emerged as a widespread element in the development of numerous illnesses, posing a severe worldwide healthcare problem [17]. Cardiovascular disorders, neurological ailments such as Alzheimer's and Parkinson's diseases, cancer, and inflammatory disorders are all associated with oxidative stress [18]. The effect of oxidative stress on cellular damage and dysfunction emphasizes its importance in the etiology of various diseases.

C. japonica a kumquat species cultivated in Egypt, is known for its sweet and fragrant rind, making the whole fruit enjoyable to eat [19]. It can be made into marmalade, added to fruit salads, or preserved in sugar syrup for the food industry [20]. Traditionally, it has been used in folk medicine to treat colds, coughs, and respiratory tract inflammations. Despite its traditional uses, its phytoconstituents and biological activities are poorly understood [21]. Previous studies identified C-glycosyl flavonoids, flavanones, and methylated aglycones as the primary phenolic compounds in C. japonica. These compounds have shown various biological effects, including antioxidant, anti-inflammatory, and anticancer properties [22].

Investigating the therapeutic potential of underutilized plant parts derived from crops is a viable approach for identifying innovative drugs with significant economic benefits [23]. Besides, Palestine is among the world's largest exporters of Citrus fruits [24]. Given the significant global healthcare challenges posed by diabetes, cancer, obesity, and diseases associated with oxidative stress, this study aims to comprehensively profile the phytochemical constituents of C. japonica leaf volatile oil (VO) from Palestine and assess its cytotoxic, antidiabetic, anti-obesity, and antioxidant activities.

Materials and methods

Plant material

C. japonica plant was recognized in An-Najah National University's Herbal Product Laboratory by a pharmacognosist, Professor Nidal Jaradat, which was then placed within a voucher specimen code (Pharm-PCT-2803). Next, fresh C. japonica leaves were gathered in the Palestinian governorate of Jenin in July 2023. After being thoroughly cleaned with distilled water to avoid contamination, the gathered leaves were dried in the absence of sunshine at a regulated temperature of no more than 25 °C and a normal humidity level. Following drying, the plant dry material was roughly ground into powder and kept in bags for later use.

Chemicals and instruments

Frutarom (Clacton-on-Sea, UK) provided the following chemical and biological materials: methanol, trolox, NaCl, Na2HPO4/NaH2PO4, DPPH, 3,5-dinitro salicylic acid (DNSA), porcine pancreatic lipase, α-amyalse, starch, and Acarbose. Besides, dimethyl sulfoxide (DMSO) was purchased from Sigma-Aldrich in Germany. In addition, the instruments, namely a shaker apparatus (Memmert, Buchenbach, Germany), a UV–visible spectrophotometer (Jenway 7135, Staffordshire, UK), a grinder (Moulinex, model LM2211, UNO, Shanghai, China), a balance (Rad wag, AS 220/c/2, Radom, Poland), gas chromatography (PerkinElmer, Clarus 500, Waltham, Massachusetts, USA), and mass spectrometer (Shelton, CT105484, Massachusetts, USA) were used in this investigation.

Volatile oil extraction

The C. japonica VO was extracted by hydrodistillation using a Clevenger device. One liter of distilled water was added to a round-bottom flask holding six hundred grams of plant leaves. This mixture was then hydrodistilled for about 4 h. The extracted oil was dried on anhydrous magnesium sulfate [25]. The extracted VO was sealed in opaque glass vials and stored at 4 °C until being utilized. On a weight-per-weight basis (w/w), the VO output was 2.22%.

Gas chromatography–mass spectrometry

Using gas chromatography connected to a Perkin Elmer Clarus 560 mass spectrometer, the phytochemical components of C. japonica VO were ascertained both qualitatively and quantitatively. A Perkin Elmer Elite-5 fused-silica capillary column (30 m × 0.25 mm, film thickness 0.25 µm) was used to separate. The column's starting temperature was set at 50 °C and maintained there for 5 min. After that, it was programmed to increase by 4 °C per minute until it reached its ultimate temperature of 280 °C. Helium was used as a carrier gas, and its flow rate was maintained at 1 mL/min for each chromatographic run. 0.2 µL of the obtained C. japonica VO was added to a split chamber at 250 °C with a splitter rate of 1:50. By comparing the mass spectra of the phytochemical components of C. japonica VO with reference samples that were already in the analyzer library (National Institute of Standards and Technology; NIST), its elements were determined. Using the homologous series of n-alkanes C6–C28 as a standard, each compound's retention index (RI) was calculated using the Kovats technique and compared to standards found in the literature [26]. The retention index was calculated from Eq. (1):

$${\text{RI}}= 100*\left[ {n + \left( {{{\left( {{\text{RT}}\left( {{\text{Samble}}} \right) - {\text{RT}}\left( n \right)} \right)} \mathord{\left/ {\vphantom {{\left( {{\text{RT}}\left( {{\text{Samble}}} \right) - {\text{RT}}\left( n \right)} \right)} {\left( {{\text{RT}}\left( N \right) - {\text{RT}}\left( n \right)} \right)}}} \right. \kern-\nulldelimiterspace} {\left( {{\text{RT}}\left( N \right) - {\text{RT}}\left( n \right)} \right)}}}\right)} \right].$$
(1)

n: the number of the preceding carbon atom of the sample in a mixture of n-alkanes. N: the number of the following carbon atoms of the sample in a mixture of n-alkanes. RT: the individual retention time.

Free radical scavenging activity

We assessed the VO’s capacity to scavenge 2,2-diphenyl-1-picrylhydrazyl (DPPH) radicals using a method previously reported [27]. A stock solution was serially diluted in this experiment to provide different concentrations (5, 7, 10, 20, 50, 80, and 100 µg/mL). Next, each sample's absorbance was evaluated at 517 nm in wavelength. A substance-free solution was combined with equal quantities of DPPH solution and methanol. Trolox was employed as the reference standard at the mentioned VO concentration. The absorbance of this solution was measured to facilitate the computation of the inhibition percentage.

$${\text{DPPH}}\;{\text{inhibition}}\;\% = \left( {{\text{B}} - {\text{Z}}} \right)/{\text{B}} \times 100\% .$$
(2)

B = absorbance of blank, Z = absorbance of the tested samples.

Porcine pancreatic lipase suppressant method

This work used the porcine pancreatic lipase inhibition test developed based on a prior investigation [28]. Five different solutions with 10, 50, 100, 500, and 700 μg/mL concentrations were diluted with methanol from a stock solution of plant VO at 1 mg/mL in 10% DMSO. The pancreatic lipase enzyme was prepared as a 1 mg/mL stock solution just prior to use. Furthermore, 20.9 mg of p-nitrophenyl butyrate (PNPB) was dissolved in 2 mL of acetonitrile to generate a stock solution. Porcine pancreatic lipase (1 mg/mL) and 0.2 mL of various VO concentrations (10, 50, 100, 300, and 400 μg/mL) were combined in separate test tubes.

The Tris–HCl solution (pH 7.4) was added, and the mixtures were incubated at 25 °C for 15 min to reach a final volume of 1 mL. Each test tube was filled with 0.1 mL of PNPB solution after incubation. The mixes were incubated at 37 °C for 30 min once more. Using a UV–visible spectrophotometer, the hydrolysis of p-nitrophenyl butyrate to p-nitrophenol at 405 nm was measured to evaluate the inhibitory activity of pancreatic lipase. Orlistat was used as a positive control, and the same protocol was followed with the previously specified concentrations. Every test was run in triplicate.

$${\text{Porcine}}\;{\text{pancreatic}}\;{\text{lipase}}\;{\text{inhibition}}\;\% = \left( {{\text{AB}} - {\text{AE}}} \right)/{\text{AB}} \times 100\% .$$
(3)

AB is the blank solution's recorded absorbance, and AE is the recorded absorbance of the oil sample solution.

α-Amylase inhibitory method

The plant-derived VO was first dissolved in a small amount of dimethyl sulfoxide (DMSO) and then diluted in a buffer solution (NaCl at 0.006 M, NaH2PO4/NaH2HPO4 at 0.02 M, and pH adjusted to 6.9) to achieve a concentration of 1 mg/mL. Subsequently, 10, 50, 70, 100, and 500 µg/mL dilutions were produced, and the reference standard Acarbose was used in the same mentioned concentrations. The following formula was used to calculate the percentage of inhibition for the α-amylase inhibitory activity:

$$\% \;{\text{of}}\;\alpha {\text{-amylase}}\;{\text{inhibition}} = \left( {B - S} \right)/B \times 100\% ,$$
(4)

where B is the absorbance of a blank; S is the absorbance of a tested sample [29].

Cytotoxicity screening

The research sought to assess the anticancer potential of C. japonica VO against different cell lines. The cell lines used in this experiment included breast cancer (MCF-7), hepatocellular carcinoma (Hep3B, HepG2), cervical cancer specimen (HeLa), and colon carcinoma (Caco-2) cells were cultured in RPMI 1640 media, while human hepatic stellate (LX-2) and skin cancer (B16F1) cells were cultured in Dulbecco's modified Eagle's medium (DMEM). After incubating all cells at 37 °C in a humid condition with 5% CO2, 2.6 × 104 cells/mL were seeded into a 96-well plate. Cells were treated for 48 h to various concentrations of the investigated VO (1000, 500, 300, 100, and 50 µg/mL) and 5-flurouracil medication (300, 100, 50, 10, and 1 µM). The Cell-Tilter 96® Aqueous One Solution Cell Proliferation (MTS) bioassay was used to assess cell viability after culture. The MTS assay was based on adding 90 µl of medium and 10 µL of MTS solution to each well, and the plates were incubated for 24 h at 37 °C before the absorbance was determined using a UV–Vis spectrophotometer at 490 nm. Equation (5) was used to calculate the cell viability percentage of VO:

$$\text{Cell viability} \left(\%\right)= \frac{\text{ODsample}}{\text{ODcontrol} }\times 100 \%,$$
(5)

where OD: optical density.

The selectivity index (SI) calculations were established by dividing the IC50 value into normal cells by the IC50 value on cancer cells:

$$\text{Selectivity index }\left(\text{SI}\right)= \frac{\text{IC}50\; \text{of}\; VO\; \text{on normal cells}}{\text{IC}50\; \text{of}\; VO\; \text{on cancer cells}}.$$
(6)

The SI value indicates the sample's selectivity to the cell lines tested. Samples with a SI > 3 was considered to have a high selectivity for tumorous cells [30].

Statistical analysis

All the experiments were carried out in triplicates. The results are presented as means ± standard deviation (SD). The statistical significance of the difference was evaluated by variance analysis (ANOVA) using an Excel program. Only p-values less than 0.005 were deemed significant.

Results and discussion

Phytochemical analysis

VOs consist of a complex combination of natural molecules that vary in concentration, ranging from 20 to 60 components, less or more. The primary components of VOs are primarily responsible for their biological and chemical characteristics. These components belong to two categories of biosynthetic origins, classified mainly from terpenoids and terpenes, which are low molecular weight aliphatic or aromatic components [31].

The yield of VO obtained for C. japonica was 2.22%. Instrumental GC–MS technology branded 45 elements, accounting for 99.69% of the total VO. The predominant molecules are γ-muurolene (28.12%), β-eudesmol (10.93%), γ-eudesmol (8.44%), germacrene B (7.39%), and elemol (7.27%) (Fig. 1, Table 1). Regarding the phytochemical classification of C. japonica VO, hydrocarbon sesquiterpene is the major class, representing 58.66%, and its major components were γ-muurolene (28.12%), germacrene B (7.39%), and elixene (5.40%). The second class of VO is oxygenated sesquiterpenoid (33.18%), and its trend molecules are β-eudesmol (10.93%), γ-eudesmol (8.44%), and elemol (7.27%). The next class is hydrocarbon monoterpene (6.38%), and the least phytochemical class is oxygenated monoterpenoid (1.46%), whose main constituent is linalool (1.30%). The hydrocarbon sesquiterpene class represented 21 compounds, followed by hydrocarbon monoterpene, oxygenated sesquiterpenoid, and oxygenated monoterpenoid, which have 10, 9, and 5 molecules, respectively.

Fig. 1
figure 1

Gas chromatography–mass spectrometry chromatogram of C. japonica leaf volatile oil

Table 1 Chemical constituents identified in the volatile oil of C. japonica leaf from Palestine

Satyal et al. reported that the VO of C. japonica from Nepal was obtained in 0.075% yield, and 42 elements accounted for 99.6% of the oil. The major compounds in the VO were linalool (35.1%), geraniol (12.7%), and trans-isomer nerol (5.3%) [32].

A study conducted by Sutour et al. found that C. japonica VO from France was dominated by germacrene D (14.9%), β-elemol (9.1%), cis-guai-6-en-10p-ol (6.3%), β-eudesmol (5.5%), and δ-elemene (5.2%) [33].

C. japonica leaves VO from Thailand; the major components were β-pinene (47.4%), limonene (10.2%), and linalool (9.8%. [34]. While the major leaf components from Vietnam were elemol (17.7%), β-eudesmol (16.6%), and epi-bicyclosesquiphellandrene (16.6%) [35]. In contrast, the C. japonica leaf VO from Egypt, the major constituents were elemol (19.4%), δ-cadinene (16.0%), γ-eudesmol (11.9%), guaiol (11.7%), and τ-cadinol (11.1%) [36].

Obviously, our studied leaf VO primary ingredients are γ-muurolene (28.12%), β-eudesmol (10.93%), γ-eudesmol (8.44%), germacrene B (7.39%), and elemol (7.27%), which are drastically different from Egyptian, France, Vietnam, and Nepalese leaves VOs.

The chemical compositions of VOs are a complex and dynamic interplay of various factors, and previous studies reported that VOs chemical ingredients can vary considerably based on the plants' location, soil composition, rainfall level, height, temperature, humidity, and sunshine exposure [37].

Porcine pancreatic α-amylase, lipase, and DPPH free radicals’ inhibitory effects

Hyperlipidemia/hypercholesterolemia and obesity are two of the main risk factors for developing signs of diabetes mellitus in people. In numerous developing regions, herbal medicine is still a popular alternative treatment. Various elements of herbal plants, including VOs, are utilized to treat diabetes and obesity [38]. Moreover, for those who have diabetes and obesity, oxidative stress is a serious risk that exacerbates their health issues. Under these circumstances, there is an increase in the risk of inflammation, insulin resistance, neurological damage, and cardiovascular diseases due to elevated levels of reactive oxygen species. Controlling oxidative stress becomes essential to halting further problems and enhancing the general health of persons with diabetes and obesity [39]. Previous investigations demonstrated that VO had antioxidant, α-amylase, and lipase inhibitory effects to help treat oxidative stress, diabetes, and obesity [40, 41].

α-Amylase inhibitory activity

Figure 2 displays the percentage of α-amylase inhibition at different concentrations and showed that both samples exhibited a rise in α-amylase inhibition with an increased concentration. At a concentration of 500 µg/mL, Acarbose inhibited the action of α-amylase by 72.54 ± 2.1%, while C. japonica VO inhibited the effect of α-amylase by 35.45 ± 0.11% (p-value < 0.005).

Fig. 2
figure 2

α-Amylase inhibitory activity by the volatile oil of C. japonica leaf and Acarbose drug

Pancreatic lipase inhibitory results

Regarding porcine pancreatic lipase, Fig. 3 reflects the C. japonica VO and Orlistat anti-obesity medication. The results showed that C. japonica VO has lipase inhibition action in a dose-dependent manner. However, at a concentration of 700 µg/mL, C. japonica VO inhibited the effect of porcine pancreatic lipase by 42.86 ± 0.16. At the same concentration, Orlistat suppressed the action of lipase enzyme by 98.25 ± 0.58% (p < 0.005). The concentration used from C. japonica VO in this study is almost similar to the one used earlier by Liu et al. [42] from protopanaxadiol type of ginsenosides that is isolated from the leaves of the American ginseng to inhibit the action of lipase. A concentration ranging from 250–1000 µg/mL was used to inhibit the activity of pancreatic lipase in the assay system.

Fig. 3
figure 3

Porcine pancreatic lipase suppressant action by C. japonica VO and Orlistat

The use of anti-obesogenic drugs is increasing, with reported side effects from dry mouth, blood pressure induction, headache, constipation, and insomnia [43]. In addition, these drugs are not affordable for everyone in the developing countries. Therefore, developing new treatments using natural medicines derived from unused parts of plants is highly advantageous. These drugs will have reduced costs and minimal or without adverse side effects [44].

Antioxidant results

Figure 4 depicts the free DPPH inhibitory actions of C. japonica leaf VO and Trolox. Trolox, a vitamin E analog, has a potent antioxidant effect and is utilized therapeutically as an official oxidative stress-reducing medication [45]. Figure 4 indicates that the C. japonica leaf VO in a depending manner and at a concentration of 100 µg/mL, the tested VO exhibited 61.17 ± 1.01% of DPPH free radical scavenging property compared with Trolox which has 95.87 ± 0.01% of DPPH free radical suppressant effect with IC50 value of 39.8 ± 1.01 and 10.23 ± 0.12 µg/mL, respectively (p < 0.005).

Fig. 4
figure 4

DPPH free radical scavenging activity by C. japonica leaf volatile oil and Trolox

Bunrathep et al. [34] examined the antioxidant properties of C. japonica leaves and peels by measuring the percentage of DPPH radical inhibition and IC50 values (μg/mL). These results were then compared to synthetic vitamin E and butylated hydroxytoluene. The researchers discovered that the leaf and peel VOs exhibited antioxidant activity, with IC50 values of 53.11 and 102.11 μg/mL, respectively. These results agreed with the Bunrathep et al. study, as our study's stable DPPH assay results had strong activity compared with Trolox with 39.8 ± 1.01 and 10.23 ± 0.12 µg/mL, respectively.

Investigators led by Dawidowicz [46] found that the antioxidant properties of VO are not always linked to the antioxidant activity of its main ingredient. It is important to understand synergistic, antagonistic, and additive effects.

The IC50 calculation revealed that the VO extracted from C. japonica leaves exhibits potent antioxidant properties and moderate inhibitory effects on lipase and α-amylase enzymes, as demonstrated by the DPPH, porcine pancreatic lipase, and α-amylase inhibitory assays.

Cytotoxic effects

Citrus fruits were explicitly examined for their potential in inhibiting mammalian DNA polymerase (pol), impeding the growth of cancer cells (particularly in human colon carcinoma, HCT116), showcasing antiallergic properties, and acting as inhibitors of anti-β-hexosaminidase release in rat basophilic leukemia RBL-2H3 cells subjected to calcium ionophore A23187 treatment. The primary focus of the investigation centered on elucidating the anticancer activity exhibited by citrus fruits [47]. Figure 5 shows that C. japonica leaf VO at a concentration of 1000 µg/mL inhibited the growth of all used cancer cell lines by a percentage higher than 90%.

Fig. 5
figure 5

Cytotoxic effects of C. japonica leaf volatile oil against a series of cells

The cytotoxic IC50 results (Table 2) highlight the notable cytotoxic effects of C. japonica VO across the various cell lines compared with the 5-flurouracil chemotherapeutic agent. In the IC50 calculations, the C. japonica VO showed the highest cytotoxic effect against Hep3B, followed by B16F1, CaCo-2, HeLa, and MCF-7, and the lowest was HepG2, with IC50 doses of 69.7 ± 2.55, 73.42 ± 1.51, 94.15 ± 1.99, 98.29 ± 2.54, 116.29 ± 1.79, and 171.96 ± 1.71 µg/mL, respectively. At the same reading, 5-Fu has IC50 doses of 13.28 ± 2.21, 12.91 ± 1.36, 3.72 ± 0.84, 2.16 ± 1.01, 1.29 ± 0.45, and 4.23 ± 1.78 µg/mL, respectively. Regarding the IC50 calculations for C. japonica VO, the results showed that the tested VO is not as toxic as at a normal cell line (LX-2) compared with the 5-Fu drug, which has IC50 values of 224.95 ± 2.03 and 0.74 ± 0.33 µg/mL, respectively. Thus, the C. japonica VO is not toxic to normal cells but has a potential cytotoxic effect against all screened cancer cells.

Table 2 Cytotoxicity test IC50 (µg/mL) values and selectivity index (SI) of C. japonica volatile oil and 5-flurouracil

Cell viability percentage was calculated for CaCo-2, HeLa, MCF-7, HepG2, Hep3B, B16F1, and LX-2 cells at various concentrations, as shown in Fig. 6. Cancer cells with the lowest cell viability at 100 µg/mL concentration were Hep3B (27.04%), CaCo-2 (35.48%), B16F1 (43.84%), and HeLa (50.27%). At the same time, they showed cell viability for MCF-7 and HepG2 cancer cells at 63.98 and 93.16%, respectively. These results indicate that the VO has significant anticancer activity, especially against liver, colon, and skin cancer cells, as this oil kills these cells by 72.96, 64.52, 56.16, and 49.73%, respectively. At the same concentration, the VO was almost not toxic to the LX-2 normal cells, as the cell viability percent was 99.99, which means that the VO inhibited the growth of the normal cells by 0.01%.

Fig. 6
figure 6

Cell viability percentages of C. japonica volatile oil against CaCo-2, HeLa, MCF-7, HepG2, Hep3B, B16F1 cancer cells, and LX-2 normal cells at various concentrations

The comparative analysis reveals the noticeable cytotoxic effect of C. japonica VO compared with 5-flurouracil drugs across diverse cell lines. These findings contribute to our understanding of this natural substance's relative efficacy and potential therapeutic applications.

All these potential bioactivities of investigated C. japonica VO may be due to the presence of γ-muurolene VO, the major component of our study, which has been demonstrated in previous research to have potential antioxidant and anti-inflammatory activities. It has also been shown to inhibit protein targets involved in cancer cell proliferation [48, 49]. Moreover, this may be due to the presence of hydrocarbon sesquiterpene, the most abundant phytochemical class in C. japonica VO (58.66%), which is shown in numerous studies to have strong antioxidant properties [50]. In addition, recent efforts in the research and development of new drugs derived from natural products have identified various sesquiterpenes that possess promising anti-carcinogenic activities [51]. Sun et al. reported that sesquiterpenes had potential cytotoxic activity against adenocarcinoma (A549), stomach cancer (BGC-823), hepatoma (Bel 7402), colon cancer (HCT-8), and HELA cell lines, with IC50 values of 1.68, 1.22, 1.91, 1.77 and 1.61 μg/mL, respectively [52]. Moreover, previous investigations have shown that sesquiterpenes have a variety of biological activities, including anticancer, antidiabetic, antimicrobial, anti-inflammatory, immune system stimulant, and antioxidant properties, making them potential targets for developing new therapeutics and medical applications [53].

It is worth mentioning that VO's bioactivities are generally not always linked to its main ingredient, and it is important to understand the synergistic, antagonistic, and additive effects of the VO mixtures in plants [49].

To the best of our knowledge, no previous studies have reported the cytotoxic, anti-obesity, and anti-lipase effects of VO extracted from the leaves of C. japonica, and the current study is the first one. Further advanced phytochemical procedures to separate the active constituents of C. japonica leaf VO, as well as in vivo and preclinical research, are required to validate the findings of our study and develop appropriate pharmaceutical dosage forms. In addition, pharmacodynamic investigations are needed to delineate the underlying mechanisms governing the observed biological effects of C. japonica VO.

Conclusion

Palestine is one of the world's largest producers of various kinds of citrus fruits, and the beneficial roles of different citrus VOs have been widely reported. However, the chemical constituents and bioactivities of some of the unutilized parts of citrus plant have not been investigated. In this study, C. japonica VO was extracted via the hydrodistillation technique, and its chemical constituents, antioxidant, cytotoxic, anti-obesity, and antidiabetic activities were investigated. The results revealed strong cytotoxicity against cancer cells and safety against normal cells. It also showed that the VO has strong antioxidant activity and activity against porcine pancreatic lipase and α-amylase enzymes in a dose-dependent manner. The results showed that C. japonica VO has potential for future pharmaceutical and food use. Further in vivo and preclinical investigations on C. japonica VO bioactivities are needed to validate these promising findings of our study.

Data availability

The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request. The datasets supporting the conclusions of this article are included in the manuscript. The raw data and materials of the current study are available from the corresponding author upon reasonable request.

References

  1. Ali B, Al-Wabel NA, Shams S, Ahamad A, Khan SA, Anwar F. Essential oils used in aromatherapy: a systemic review. Asian Pac J Trop Biomed. 2015;5(8):601–11.

    Article  Google Scholar 

  2. Sharifi-Rad J, Sureda A, Tenore GC, Daglia M, Sharifi-Rad M, Valussi M, Tundis R, Sharifi-Rad M, Loizzo MR, Ademiluyi AO. Biological activities of essential oils: from plant chemoecology to traditional healing systems. Molecules. 2017;22(1):70.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Cimino C, Maurel OM, Musumeci T, Bonaccorso A, Drago F, Souto EMB, Pignatello R, Carbone C. Essential oils: pharmaceutical applications and encapsulation strategies into lipid-based delivery systems. Pharmaceutics. 2021;13(3):327.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Dagli N, Dagli R, Mahmoud RS, Baroudi K. Essential oils, their therapeutic properties, and implication in dentistry: a review. J Int Soc Prev Community Dent. 2015;5(5):335.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Lakhan SE, Sheafer H, Tepper D. The effectiveness of aromatherapy in reducing pain: a systematic review and meta-analysis. Pain Res Treat. 2016. https://doi.org/10.1155/2016/8158693.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Bona E, Massa N, Novello G, Pavan M, Rocchetti A, Berta G, Gamalero E. Essential oil antibacterial activity against methicillin-resistant and-susceptible Staphylococcus aureus strains. Microbiol Res. 2019;10(1):8331.

    Article  Google Scholar 

  7. Quijano CE, Pino JA. Volatile compounds of round Kumquat (Fortunella japonica Swingle) peel oil from Colombia. J Essential Oil Res. 2009. https://doi.org/10.1080/10412905.2009.9700224.

    Article  Google Scholar 

  8. Chia JMX, Goh ZZS, Chua ZY, Ng KYY, Ishak D, Fung SM, Ngeow JYY, Griva K. Managing cancer in context of pandemic: a qualitative study to explore the emotional and behavioural responses of patients with cancer and their caregivers to COVID-19. BMJ Open. 2021;11(1): e041070.

    Article  PubMed  Google Scholar 

  9. Pramesh C, Badwe RA, Bhoo-Pathy N, Booth CM, Chinnaswamy G, Dare AJ, de Andrade VP, Hunter DJ, Gopal S, Gospodarowicz M. Priorities for cancer research in low-and middle-income countries: a global perspective. Nat Med. 2022;28(4):649–57.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Hawash M, Jaradat N, Shekfeh S, Abualhasan M, Eid AM, Issa L. Molecular docking, chemo-informatic properties, alpha-amylase, and lipase inhibition studies of benzodioxol derivatives. BMC Chem. 2021;15(1):1–10.

    Article  Google Scholar 

  11. Alkaiyat A, Hilo L, Braik T, Sayeh W, Alem I. Adherence to the management of type I diabetes among Palestinian patients in Nablus city: a cross-sectional study. Palest Med Pharm J. 2022;5(2):125–32.

    Google Scholar 

  12. Diabetes. https://www.who.int/news-room/fact-sheets/detail/diabetes#:~:text=The%20number%20of%20people%20with,stroke%20and%20lower%20limb%20amputation.

  13. Afroz A, Alramadan MJ, Hossain MN, Romero L, Alam K, Magliano DJ, Billah B. Cost-of-illness of type 2 diabetes mellitus in low and lower-middle income countries: a systematic review. BMC Health Serv Res. 2018;18(1):1–10.

    Article  Google Scholar 

  14. Jaradat N, Qadi M, Ali I, Hussein F, Issa L, Rashdan D, Jamoos M, Ra N, Zarour A, Arar M. Phytochemical screening, anti-obesity, antidiabetic and antimicrobial assessments of Orobanche aegyptiaca from Palestine. BMC Complementary Med Ther. 2021;21(1):1–8.

    Google Scholar 

  15. Jaradat N, Khasati A, Hawi M, Hawash M, Shekfeh S, Qneibi M, Eid AM, Arar M, Qaoud MT. Antidiabetic, antioxidant, and anti-obesity effects of phenylthio-ethyl benzoate derivatives, and molecular docking study regarding α-amylase enzyme. Sci Rep. 2022;12(1):1–9.

    Article  Google Scholar 

  16. Sørensen TI, Martinez AR, Jørgensen TSH. Epidemiology of obesity. In: Eckel J, Clément K, editors. From obesity to diabetes. Cham: Springer International Publishing; 2022. p. 3–27. https://doi.org/10.1007/164_2022_581.

    Chapter  Google Scholar 

  17. Dama A, Shpati K, Daliu P, Dumur S, Gorica E, Santini A. Targeting metabolic diseases: the role of nutraceuticals in modulating oxidative stress and inflammation. Nutrients. 2024;16(4):507.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Taş S, Sarandöl E, Dirican M. Vitamin B6 supplementation improves oxidative stress and enhances serum paraoxonase/arylesterase activities in streptozotocin-induced diabetic rats. Sci World J. 2014. https://doi.org/10.1155/2014/351598.

    Article  Google Scholar 

  19. Abobatta WF. Citrus varieties in Egypt: an impression. Int Res J Appl Sci. 2019;1:63–6.

    Google Scholar 

  20. Lou S-N, Ho C-T. Phenolic compounds and biological activities of small-size citrus: kumquat and calamondin. J Food Drug Anal. 2017;25(1):162–75.

    Article  CAS  PubMed  Google Scholar 

  21. Nouri A, Shafaghatlonbar A. Chemical constituents and antioxidant activity of essential oil and organic extract from the peel and kernel parts of Citrus japonica Thunb. (kumquat) from Iran. Nat Prod Res. 2016;30(9):1093–7.

    Article  CAS  PubMed  Google Scholar 

  22. Ragheb AY, Masoud MA, El Shabrawy MO, Farid MM, Hegazi NM, Mohammed RS, Marzouk MM, Aboutabl ME. MS/MS-based molecular networking for mapping the chemical diversity of the pulp and peel extracts from Citrus japonica Thunb.; in vivo evaluation of their anti-inflammatory and anti-ulcer potential. Sci Afr. 2023;20: e01672.

    CAS  Google Scholar 

  23. Mudau FN, Chimonyo VGP, Modi AT, Mabhaudhi T. Neglected and underutilised crops: a systematic review of their potential as food and herbal medicinal crops in South Africa. Front Pharmacol. 2022;12: 809866.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Saraiva T. 3 Cloning as orientalism: reproducing citrus in mandatory Palestine. USA: University of Chicago Press; 2021.

    Google Scholar 

  25. Milenković A, Stanojević J, Cvetković D, Stanojević L. Chemical composition and antioxidant activity of black pepper (Piper nigrum L.) fructus essential oil hydrodistillation fractions. J Essent Oil Bearing Plants. 2024. https://doi.org/10.1080/0972060X.2024.2315581.

    Article  Google Scholar 

  26. Kind T, Wohlgemuth G, Lee DY, Lu Y, Palazoglu M, Shahbaz S, Fiehn O. FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. Anal Chem. 2009;81(24):10038–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Alqub M, Jaradat N. In vitro studies of Bituminaria bituminosa L. extracts from Palestine for their antioxidant, qualitative, and quantitative properties. Palest Med Pharm J. 2023;8(1):8.

    Article  Google Scholar 

  28. Bustanji Y, Issa A, Mohammad M, Hudaib M, Tawah K, Alkhatib H, Almasri I, Al-Khalidi B. Inhibition of hormone sensitive lipase and pancreatic lipase by Rosmarinus officinalis extract and selected phenolic constituents. J Med Plants Res. 2010;4(21):2235–42.

    Google Scholar 

  29. Nishiyama J, Kuninori T, Matsumoto H. The use of 1, 1-diphenyl-2-picrylhydrazyl for detecting free radicals in wheat flour dough. J Sci Food Agric. 1978;29(3):267–73.

    Article  CAS  Google Scholar 

  30. Hawash M, Jaradat N, Abualhasan M, Şüküroğlu MK, Qaoud MT, Kahraman DC, Daraghmeh H, Maslamani L, Sawafta M, Ratrout A, et al. Design, synthesis, molecular docking studies and biological evaluation of thiazole carboxamide derivatives as COX inhibitors. BMC Chem. 2023;17(1):11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Bakkali F, Averbeck S, Averbeck D, Idaomar M. Biological effects of essential oils—a review. Food Chem Toxicol. 2008;46(2):446–75.

    Article  CAS  PubMed  Google Scholar 

  32. Satyal P, Paudel P, Limbu K, Setzer WN. Leaf essential oil composition of Citrus japonica from Nepal. J Essent Oil Bear Plants. 2012;15(3):357–9.

    Article  CAS  Google Scholar 

  33. Sutour S, Luro F, Casanova J, Tomi F. Integrated analysis by GC (RI), GC-MS and 13C NMR of Fortunella japonica leaf volatiles obtained by hydrodistillation, microwave-assisted hydrodistillation and hydrolate extraction. Nat Prod Commun. 2017;12(3):1934578X1701200331.

    CAS  Google Scholar 

  34. Bunrathep S, Soodvilai S, Settharaksa S, Palanuvej C. Chemical constituents and biological activities of Fortunella japonica essential oils. Interprof J Health Sci. 2015;13(1):43–9.

    Google Scholar 

  35. Trinh HH, Nguyen TTT, Le TN. Study of peel and leaf calamondin oil, Fortunella japonica Thumb. Vnuhcm J Sci Technol Dev. 2009;12(10):41–7.

    Article  Google Scholar 

  36. El-Gizawy H, Osman S, Abdelkawy M, Koheil M, El Halawany A, Hussein M. Seasonal variation of essential oil, oxygenated compounds content and antioxidant capacities of leaves and ripe and unripe fruits of Fortunella japonica Swingle (kumquat). World J Med. 2013;1:204–15.

    Google Scholar 

  37. Tursun AO. Impact of soil types on chemical composition of essential oil of purple basil. Saudi J Biol Sci. 2022;29(7): 103314.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Bozkurt B, Aguilar D, Deswal A, Dunbar SB, Francis GS, Horwich T, Jessup M, Kosiborod M, Pritchett AM, Ramasubbu K. Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association. Circulation. 2016;134(23):e535–78.

    Article  PubMed  Google Scholar 

  39. Bassalat N, TaÅŸ S, Jaradat N. Teucrium leucocladum: an effective tool for the treatment of hyperglycemia, hyperlipidemia, and oxidative stress in streptozotocin-induced diabetic rats. Evid-based Complementary Altern Med. 2020. https://doi.org/10.1155/2020/3272103.

    Article  Google Scholar 

  40. Jaradat N. Phytochemical profile and in vitro antioxidant, antimicrobial, vital physiological enzymes inhibitory and cytotoxic effects of artemisia jordanica leaves essential oil from Palestine. Molecules. 2021;26(9):2831.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Jaradat NA, Zaid AN, Abuzant A, Shawahna R. Investigation the efficiency of various methods of volatile oil extraction from Trichodesma africanum and their impact on the antioxidant and antimicrobial activities. J Intercult Ethnopharmacol. 2016;5(3):250.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Liu R, Zhang J, Liu W, Kimura Y, Zheng Y. Anti-obesity effects of protopanaxdiol types of ginsenosides isolated from the leaves of American ginseng (Panax quinquefolius L.) in mice fed with a high-fat diet. Fitoterapia. 2010;81(8):1079–87.

    Article  CAS  PubMed  Google Scholar 

  43. Karamadoukis L, Shivashankar G, Ludeman L, Williams A. An unusual complication of treatment with orlistat. Clin Nephrol. 2009;71(4):430–2.

    Article  CAS  PubMed  Google Scholar 

  44. Mopuri R, Islam MS. Medicinal plants and phytochemicals with anti-obesogenic potentials: a review. Biomed Pharmacother. 2017;89:1442–52.

    Article  CAS  PubMed  Google Scholar 

  45. Atiq A, Lee HJ, Khan A, Kang MH, Rehman IU, Ahmad R, Tahir M, Ali J, Choe K, Park JS. Vitamin E analog trolox attenuates MPTP-induced Parkinson’s disease in mice, mitigating oxidative stress, neuroinflammation, and motor impairment. Int J Mol Sci. 2023;24(12):9942.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Dawidowicz AL, Olszowy M. Does antioxidant properties of the main component of essential oil reflect its antioxidant properties? The comparison of antioxidant properties of essential oils and their main components. Nat Prod Res. 2014;28(22):1952–63.

    Article  CAS  PubMed  Google Scholar 

  47. Mitoshi M, Kuriyama I, Nakayama H, Miyazato H, Sugimoto K, Kobayashi Y, Jippo T, Kanazawa K, Yoshida H, Mizushina Y. Effects of essential oils from herbal plants and citrus fruits on DNA polymerase inhibitory, cancer cell growth inhibitory, antiallergic, and antioxidant activities. J Agric Food Chem. 2012;60(45):11343–50.

    Article  CAS  PubMed  Google Scholar 

  48. Costa RG, da Anunciação TA, Araujo MdS, Souza CA, Dias RB, Sales CB, Rocha CA, Soares MB, da Silva FM, Koolen HH. In vitro and in vivo growth inhibition of human acute promyelocytic leukemia HL-60 cells by Guatteria megalophylla Diels (Annonaceae) leaf essential oil. Biomed Pharmacotherapy. 2020;122: 109713.

    Article  CAS  Google Scholar 

  49. de Sousa DP, Damasceno ROS, Amorati R, Elshabrawy HA, de Castro RD, Bezerra DP, Nunes VRV, Gomes RC, Lima TC. Essential oils: chemistry and pharmacological activities. Biomolecules. 2023;13(7):1144.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Khan A, Khan H, Hussain J, Adnan M, Hussain I, Khan T, Khan A. Sesquiterpenes: the potent antioxidants. Pak J Sci Ind Res. 2008;51(6):343–50.

    CAS  Google Scholar 

  51. Bartikova H, Hanusova V, Skalova L, Ambroz M, Bousova I. Antioxidant, pro-oxidant and other biological activities of sesquiterpenes. Curr Top Med Chem. 2014;14(22):2478–94.

    Article  CAS  PubMed  Google Scholar 

  52. Sun J, Shi D, Ma M, Li S, Wang S, Han L, Yang Y, Fan X, Shi J, He L. Sesquiterpenes from the red alga Laurencia tristicha. J Nat Prod. 2005;68(6):915–9.

    Article  CAS  PubMed  Google Scholar 

  53. Maurya A, Mohan S, Verma SC. Antidiabetic potential of naturally occurring sesquiterpenes: a review. Curr Top Med Chem. 2021;21(10):851–62.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge the Department of Pharmacy, faculty of Medicine and Health Sciences at An-Najah National University.

Funding

Not funded.

Author information

Authors and Affiliations

Authors

Contributions

Nidal Jaradat conceived and designed the present study. Nidal Jaradat, Ruba Atiani, Ghufran Omariyah, Lama Hamodi, Heba Mosa, Fatima Hussein, Linda Issa and Shurooq Sobuh experimented. Nidal Jaradat, Nawaf Al-Maharik, Mohammed Hawash, Trobjon Makhkamov, Komolitdin Sultonov, Marah S. Shakhshir, and Nilufar Abdullayeva analyzed the data. Nidal Jaradat wrote and revised the manuscript. All authors reviewed the paper and read and agreed to the published version of the manuscript..

Corresponding author

Correspondence to Nidal Jaradat.

Ethics declarations

Ethics approval and consent to participate

The collection of the plant material was complying with the Guidelines for the Assessment of Herbal Medicines and Legislation.

Consent for publication

The authors of the current work gave consent for publication to Professor Nidal Jaradat.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jaradat, N., Hawash, M., Al-Maharik, N. et al. Phytochemical profiling and bioactivity analysis of Citrus japonica leaves volatile oil from Palestine. Chem. Biol. Technol. Agric. 11, 140 (2024). https://doi.org/10.1186/s40538-024-00659-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40538-024-00659-w

Keywords